Protocol for the feasibility and acceptability of a brief routine weight management intervention for postnatal women embedded within the national child immunisation programme: randomised controlled cluster feasibility trial with nested qualitative study (PIMMS-WL) by Helen M Parretti (8123885) et al.
1Parretti HM, et al. BMJ Open 2020;10:e033027. doi:10.1136/bmjopen-2019-033027
Open access 
Protocol for the feasibility and 
acceptability of a brief routine weight 
management intervention for postnatal 
women embedded within the national 
child immunisation programme: 
randomised controlled cluster feasibility 
trial with nested qualitative 
study (PIMMS- WL)
Helen M Parretti,1 Natalie J Ives,2 Sarah Tearne,2 Alexandra Vince,2 
Sheila M Greenfield,1 Kate Jolly,1 Susan A Jebb,3 Emma Frew,1 Lucy Yardley,4,5 
Paul Little,6 Ruth V Pritchett,1 Amanda Daley   7
To cite: Parretti HM, Ives NJ, 
Tearne S, et al.  Protocol for 
the feasibility and acceptability 
of a brief routine weight 
management intervention for 
postnatal women embedded 
within the national child 
immunisation programme: 
randomised controlled 
cluster feasibility trial with 
nested qualitative study 
(PIMMS- WL). BMJ Open 
2020;10:e033027. doi:10.1136/
bmjopen-2019-033027
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
033027).
Received 17 July 2019
Revised 16 December 2019
Accepted 07 January 2020
For numbered affiliations see 
end of article.
Correspondence to
Professor Amanda Daley;  
 a. daley@ lboro. ac. uk
Protocol
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY. 
Published by BMJ.
AbstrACt
Introduction On average women retain 5 to 9 kg 1 year 
after giving birth which can increase the risk of later 
obesity and chronic diseases. Some previous trials in this 
population have been effective in reducing weight, but are 
too intensive and costly to deliver at scale. There is a need 
for low- cost interventions to facilitate weight loss in this 
population.
Methods and analysis The primary aim is to assess the 
feasibility of delivering a weight management intervention 
for overweight/obese postnatal women within child 
immunisation appointments. We will conduct a randomised 
controlled cluster feasibility trial with a nested qualitative 
study to assess study recruitment and acceptability of 
the intervention. Generalpractitioner practice (cluster) will 
be the unit of randomisation, with practices randomised 
to offer usual care plus the intervention or usual care 
only. Eighty women will be recruited. The intervention 
group will be offered brief support that encourages self- 
management of weight when attending child immunisation 
appointments. Practice nurses will encourage women 
to weigh themselves weekly and record this, and to 
make healthy lifestyle choices through using an online 
weight management programme. Women will be advised 
to aim for 0.5 to 1 kg/week weight loss. At each child 
immunisation the nurse will assess progress by weighing 
women. The comparator group will receive a healthy 
lifestyle leaflet. Data on weight, body fat, depression, 
anxiety, body image, eating behaviours and physical 
activity will be collected at baseline and follow- up. Women 
and nurses will be interviewed to ascertain their views 
about the intervention. The decision to proceed to the 
phase III trial will be based on prespecified stop- go criteria.
Ethics and dissemination Data will be stored securely at 
the University of Birmingham. Results will be disseminated 
through academic publications and presentations and will 
inform a possible phase III trial. The National Research 
Ethics Committee approved the study protocol.
trial registration number ISRCTN12209332
IntroduCtIon
Pregnancy is associated with significant 
weight gain and many women report preg-
nancy as the critical point for the onset of 
excess weight.1 2 The postnatal period is 
characterised not only by weight retention, 
but also susceptibility to further weight gain, 
which can significantly increase the risk of 
later obesity and serious chronic diseases.3–5 
There is also an association between postnatal 
weight retention and poor mental health.6–8 
It is estimated that on average women gain 
strengths and limitations of this study
 ► This is the first study to assess the feasibility of 
embedding a weight management intervention for 
postnatal women within usual care contacts in pri-
mary care.
 ► This study uses mixed methods and will draw on 
both quantitative and qualitative data to assess the 
feasibility and acceptability of the intervention.
 ► The intervention is based on self- regulation theory 
with external accountability.
 ► Rather than relying on self- reports, the study uses 
objective recordings from real time weighing scales 
to assess the frequency of self- weighing.
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about 14 to 15 kg during pregnancy and at 1 year after 
birth 5 to 9 kg is retained.2 3 9 10 Of women who are over-
weight prior to conception, 44% are living with obesity 
by 1 year after giving birth, while 97% of women who 
are living with obesity prior to pregnancy remain so at 
1 year postnatally.5 Therefore, there is a need to intervene 
routinely in the postnatal period, to help women manage 
their weight after having a baby and minimise long- term 
health risks.
Several systematic reviews have identified the need for 
high quality trials on how to best help women to lose 
weight after having a baby.11–16 Within these reviews, the 
vast majority of studies have recruited small sample sizes 
and evaluated intensive physical activity and/or dietary 
interventions delivered by specialists; while these types of 
interventions can be effective, they cannot be delivered 
to all the women who give birth each year in the UK, of 
whom nearly two- thirds will be living with overweight.17 
A recent systematic review of reviews of lifestyle interven-
tions for postnatal weight management highlighted the 
lack of studies that have tested an intervention embedded 
within routine healthcare.16
self-management strategies and weight loss
A systematic review of randomised controlled trials 
(RCTs) to determine the effectiveness of self- help inter-
ventions for weight loss,18 has shown that self- help inter-
ventions can lead to small, but significantly greater weight 
loss than unsupported attempts to lose weight at 6 months 
compared with minimal interventions. In the small group 
of studies providing data at 12 months, weight loss was 
no longer significant, suggesting that self- help inter-
ventions on their own may not be useful for sustaining 
long- term weight loss, and that additional components, 
within weight loss interventions are required. Nonethe-
less, given the potential scalability and relatively low cost 
of this type of intervention, self- help programmes may be 
a useful component within a broader intervention to treat 
those who are overweight.
Self- monitoring of weight by regular weighing is 
common to many self- management interventions. The 
potential efficacy of regular weighing is based on the 
principles of self- regulation theory.19 20 Self- regulation 
theory describes three distinct stages; self- monitoring, 
self- evaluation and self- reinforcement. Self- monitoring 
is a method of systematic self- observation, periodical 
measurement and recording of target behaviours with 
the goal of increasing self- awareness. The awareness 
fostered during self- monitoring is an essential initial step 
in promoting and sustaining behaviour change. Strong 
evidence supports the role of self- monitoring as an effec-
tive strategy in the health behaviour change process. 
Reviews by Michie et al of effective behavioural techniques 
for healthy eating, physical activity and reduction of 
alcohol consumption concluded that self- monitoring was 
effective alone, but when combined with other techniques 
the effect size nearly doubled.21 22 In a systematic review 
of RCTs to examine the effectiveness of self- weighing 
as a strategy for weight loss, multi- component interven-
tions including self- weighing compared with no/minimal 
control also resulted in mean differences of −3.7 kg 
(95% CI −4.6 to −2.9).23
Accountability/audit and feedback
There has been some evidence to suggest that adding 
accountability to a self- weighing programme increases 
weight loss.23 In a review by Madigan et al, in 13 of the 
included trials, the intervention group asked to weigh 
themselves knew that they were accountable to a thera-
pist/researcher, while this was not the case in two trials. 
There was a significant difference in mean weight loss 
between intervention and control for those trials with 
accountability compared with those without (−4.0 kg, 
95% CI −5.0 to −3.0 kg vs −2.3 kg, 95% CI −3.1 to −1.5 kg; 
p=0.007).23 Participants in group weight loss programmes 
often report that it is the weekly weigh- in that is the most 
salient component of the programme, providing external 
accountability and keeping them committed to their diet 
and physical activity plan.24 Based on this evidence, it can 
be hypothesised that including accountability/audit to 
self- help and self- monitoring interventions could further 
facilitate weight loss.
Internet-based weight management interventions
The widespread use of technology has led to an interest in 
digital health interventions, including for weight manage-
ment. Systematic reviews of eHealth or web- based inter-
ventions for weight loss and/or maintenance in adults 
have found that these interventions can result in modest 
weight loss in individuals with overweight or obesity.25 26 
One such digital interventions is the POWeR (Positive 
Online Weight Reduction) online weight management 
programme.27 The POWeR programme was designed for 
use with minimal additional support and was developed 
with extensive user feedback; the development process 
and content of the POWeR intervention is described else-
where.28 29 The POWeR programme has been shown to 
result in significant weight loss at 12 months in primary 
care patients with overweight when combined with brief 
nurse support.27 It focusses principally on fostering users’ 
self- regulation skills for autonomously self- managing their 
weight, rather than providing detailed dietetic advice. A 
recent systematic review concluded that internet- based 
weight management interventions for postnatal mothers 
appear to be beneficial, and survey study results have 
reported that irrespective of age or socioeconomic status, 
90.5% of new mothers use the internet as a source of 
information with weight loss as the fourth most searched 
topic.20–31 Therefore, based on this evidence it may be 
hypothesised that including an online intervention may 
be beneficial for postnatal weight loss.
study rationale
There is a need to support women to lose excess weight 
in the postnatal period. Given the large numbers of 
women who give birth each year either with pre- existing 
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Figure 1 Study flow diagram. BWCH,Birmingham 
Women’s and Children’s NHS Foundation Trust; GP, general 
practitioner; NHS,National Health Service.
overweight or obesity, or who gain excess weight during 
this period, an intervention is needed that can be deliv-
ered at scale without significant implications for a health-
care workforce. In addition, the National Institute for 
Health and Care Excellence (NICE) has highlighted the 
low quality of previous research as a limitation to devel-
oping clinical guidance in this area.32 Here we investigate 
the feasibility of a postnatal weight management interven-
tion embedded within pre- existing healthcare contacts. 
This pragmatic intervention is based on existing evidence 
for the effectiveness of both self- monitoring and an online 
programme for weight management (POWeR).19 27
Aims and objectives
The primary objective is to produce evidence that a large- 
scale phase III cluster RCT of a weight management inter-
vention embedded in the national child immunisation 
programme33 would be acceptable to women and feasible 
to conduct. Detailed objectives are listed in online supple-
mentary table 1. This protocol is reported according to 
the Standard Protocol Items Recommendations for Inter-
ventional Trials guidelines.34
MEthods And AnAlysIs
trial design
PIMMS- WL is a feasibility cluster RCT to assess the feasi-
bility and acceptability of a weight management inter-
vention, based on self- regulation theory, in women who 
have recently given birth.20 This will be assessed through a 
composite of quantitative and qualitative data. Key stages 
of the study are shown in figure 1.
trial setting
This study will take place in Birmingham, UK, between 01 
September 2017 and 31 October 2019. The initial iden-
tification of women will take place within Birmingham 
Women and Children’s NHS Foundation Trust and within 
participating generalpractitioner (GP) practices, and the 
trial will take place within GP practices around the West 
Midlands. The baseline and follow- up assessments will be 
completed in participants’ homes.
Study participants
Women will be eligible if they are aged ≥18 years, are at 
least 4 weeks postnatal, have a body mass index (BMI) 
≥25 kg/m2 at the time of recruitment, are able to provide 
written informed consent and do not meet any of the 
exclusion criteria (online supplementary table 2). Given 
that the intervention is embedded in immunisation 
appointments to be eligible, women need to have not yet 
attended their child’s first immunisation appointment 
and to be planning to have their child immunised.
Consent
Written informed consent into the PIMMS- WL trial will 
be a two- stage process conducted by a researcher at the 
baseline home visit (see online supplementary appendix 
1 for Informed Consent Forms). First, written informed 
consent will be sought for screening to confirm all eligi-
bility criteria are met. Once all eligibility criteria have 
been confirmed, participants will be invited to give their 
written informed consent to be enrolled into the RCT.
sample size and recruitment
This is a feasibility trial therefore a formal sample size 
calculation has not been conducted. The trial is not 
designed or powered to detect a statistically significant 
difference in effectiveness between the two treatment 
groups.
We will recruit 10 to 12 GP practices (clusters) across 
Birmingham, UK, and the list of participating practices 
will be held by Birmingham Clinical Trials Unit (BCTU). 
We will then aim to recruit 80 participants from these 
GP practices over 8 months. Potentially eligible partici-
pants will be identified initially from medical records at 
Birmingham Women’s and Children’s NHS Foundation 
Trust (BWCH). Initial screening of medical records by 
BWCH will confirm the women is aged ≥18 years, has 
given birth at least 4 weeks previously and is registered at a 
participating GP practice. We will exclude mothers whose 
babies have died or have been removed from their care.
A trial invitation letter and participant information 
sheet (PIS) will be mailed to potentially eligible women 
by BWCH, which includes a telephone number to call or 
a reply slip to return if they are interested in participating. 
Interested women will undergo telephone screening for 
eligibility. For women who fulfil the initial screening 
criteria and are still interested in taking part in the trial, 
a baseline home visit with a researcher will be organised.
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Some additional recruitment strategies may also be 
used if required:
 ► Posters and flyers advertising the study will be displayed 
in waiting rooms at participating GP practices.
 ► Participants may be informed about the trial directly at 
appointments with the GP or other healthcare profes-
sional post- delivery and prior to the 2- month immuni-
sation appointment in participating GP practices.
 ► A researcher may be available at the GP practice on 
specific clinic dates. The PIMMS- WL researcher will 
provide potential participants with the letter of invita-
tion and PIS directly either to read at the GP practice 
or for the participant to take home.
If, after having read the letter of invitation and PIS, 
a woman is interested in participating, they will contact 
the PIMMS- WL research team for telephone screening 
(or be screened by the PIMMS- WL researcher at the GP 
practice) and a baseline home visit will be arranged as 
described above.
randomisation
The unit of randomisation is the GP practice (cluster). 
GP practices will be randomised in a 1:1 ratio to provide 
the usual care plus a weight management intervention or 
usual care only (comparator group) using minimisation 
for GP practice list size (large: 6000 or more; small: under 
6000 patients) and Index of Multiple Deprivation (IMD) 
rank score.35 The IMD will be based on the postcode of the 
GP practice; the IMD rank score ranges from 1 to 32 844 
and will be divided into tertiles of high, medium and low 
levels of deprivation. BCTU will create the randomisation 
list to allocate GP practices to the two trial groups.
trial intervention (usual care plus weight management group)
The intervention will be delivered within the national 
child immunisation programme to minimise costs and 
additional burden on the National Health Service (NHS) 
workforce and avoid the need for additional contacts with 
health professionals at this busy time in women’s lives. In 
the first year, babies are routinely immunised at 2, 3, 4 
and 12 months of age; we plan to embed the interven-
tion within these pre- existing immunisation contacts. 
The intervention group will be offered brief support 
that encourages active self- management of weight in the 
postnatal period when they attend their practice to have 
their child immunised during the first year of life. The 
intervention involves motivation and support by nurses 
to encourage women in the postnatal period to make 
healthier lifestyle choices through self- monitoring of 
weight and signposting to an online weight management 
programme (POWeR).27
Women will be provided with weighing scales and 
asked to weigh themselves weekly. The intervention will 
be delivered until the third immunisation appointment. 
Women will be advised and encouraged to record their 
weight on a weight record card that will be attached to the 
child health record (the ‘red book’) and also within the 
POWeR online programme.27 The ‘red book’ includes a 
record of infant examinations and investigations, growth 
and immunisation history.
Weight loss goals
No clinical guidelines exist for rates of healthy weight 
loss for postnatal women, but for the general population 
NICE recommend 0.5 to 1 kg per week.36 Women will 
be advised to aim for 0.5 to 1 kg/week weight loss until 
they have achieved a BMI less than 25 kg/m2 and are no 
heavier than their self- reported pre- pregnant weight.
Accountability
Practice nurses will weigh the women at each child immu-
nisation visit and record this weight as a source of regular 
external accountability. They will not provide any weight 
management advice.
online weight loss programme (PoWer)
Nurses will signpost women to the POWeR online 
weight loss programme for support and assistance with 
goal setting, action planning and implementation of 
changes to their lifestyle. Information about breast 
feeding and weight loss (such as diet, physical activity 
and rate of recommended weight loss) will be added to 
the programme for the purpose of this trial. Women will 
be encouraged to use the website weekly to track their 
weight, set and review eating and physical activity goals 
and receive personalised advice.
Training of practice nurses
All nurses who deliver child immunisations at interven-
tion practices will be trained to deliver the intervention 
following a standard protocol. A training manual will be 
provided, with instructions for the tasks to be undertaken 
by nurses during immunisation appointments.
Intervention fidelity
Two immunisation/intervention consultations per nurse 
will be audio recorded so that intervention fidelity can 
be assessed against an intervention checklist criteria, 
and the length of time taken to deliver the intervention 
monitored.
usual care group
Women enrolled into the trial and registered at GP prac-
tices in the usual care comparator group will receive brief 
written information about following a healthy lifestyle 
using the NHS Eatwell guide leaflet.37
Masking
It is not possible to mask participants or those providing 
the intervention to group allocation. In this feasibility 
study, it is also not possible to mask the outcome assessor, 
as the same member of the PIMMS- WL research team 
will need to undertake both the baseline and follow- up 
home visit to collect data. We do not believe this will intro-
duce bias, as the aim of this study is to assess the feasi-
bility of undertaking a large phase III cluster RCT, and 
these outcomes are not affected by knowledge of group 
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allocation and the data relating to the feasibility outcomes 
are not collected during the home visits. The proposed 
primary outcome for the phase III trial is weight which is 
objectively measured using scales.
baseline assessment and follow-up
Baseline visit
The baseline visit will occur between 6 to 7 weeks postna-
tally and before the first immunisation visit.
Follow-up visit
A follow- up visit will take place 3 months post baseline. 
Women in the intervention group will be invited to partic-
ipate in the qualitative study interview (see below). A £20 
gift voucher will be given to participants as reimburse-
ment for any inconvenience and expenses incurred.
Patient and public involvement
Members of the CLAHRC- WM (Collaboration for 
Leadership in Applied Health Research and Care West 
Midlands) maternity patient and public involvement 
(PPI) group (PRIME) provided input into the develop-
ment of this study. They gave advice on the relevance of 
the study question based on their experiences and their 
assessment of the burden of the intervention on potential 
participants. Two members of the public will be invited to 
join the Trial Steering Committee (TSC). The PPI group 
will meet three times a year and will provide input into 
the topic guide for the qualitative interviews and have 
input into and review all patient facing documents. They 
will review all dissemination materials and be involved in 
the dissemination of the trial results.
Primary outcome
The primary outcome is the feasibility of undertaking a 
full- scale phase III cluster RCT, and will include assess-
ment of the following:
 ► Whether the trial is appealing to women (via assess-
ment of the recruitment rate to ensure a full phase III 
trial is feasible);
 ► Whether the intervention is acceptable;
 ► Whether the intervention has any adverse impact on 
infant immunisation rates;
 ► The number of women who complete the trial and 
complete the trial questionnaires.
The decision to proceed will be based on prespecified 
stop- go criteria (see online supplementary table 3).
outcome data
Outcome data will be collected at baseline and 3 months 
follow- up (except height (baseline only)). While this 
feasibility trial will not be powered to detect meaningful 
differences in outcome measures, it will give us the oppor-
tunity to ensure that there are no issues with the comple-
tion of these measures in a main trial. Height and weight 
will be measured at baseline to calculate BMI. Weight 
and percentage body fat will be assessed using a Tanita 
SC- 240MA analyser using a standardised procedure 
(eg, light clothing). Demographic (eg, age, ethnicity, 
socioeconomic status), lifestyle and pregnancy related 
information (eg, history of pregnancy related problems, 
mode of delivery), infant feeding practices and maternal 
sleeping patterns will be collected. Anxiety and depression 
will be assessed using the Hospital Anxiety and Depres-
sion Scale, body image using the Body Image State Scale, 
eating habits using the three- factor eating questionnaire 
and self- reported physical activity will be measured using 
the Pregnancy Physical Activity Questionnaire.38–41
At follow- up, self- weighing will be assessed using the 
Daily Self- Weighing Perceptions Questionnaire and 
weight control strategies using the Weight Control Strat-
egies Scale.42 We will also record whether the usual care 
group have accessed the POWeR website to assess any 
intervention contamination. To inform the design of the 
economic evaluation in the phase III trial, we will explore 
the acceptability of the ICECAP instrument,43 a broader 
measure of health than the EQ- 5D44 that focusses on 
general well- being. This will be done by assessing rates of 
completion of the ICECAP, and incorporating questions 
about the acceptability of the ICECAP into the qualitative 
interviews.
Eating behaviours (both groups)
Our hypothesis is that regular self- weighing and moni-
toring of weight leads to the development of self- 
regulation and conscious cognitive energy restraint.20 45 
Using the revised three- factor eating questionnaire,41 we 
will examine if feedback from self- weighing has led to 
development of conscious cognitive energy restraint of 
eating. We will also measure uncontrolled eating and 
emotional eating.
Weight control strategies (both groups)
Weight control strategies will be assessed at follow- up in 
both groups using the Weight Control Strategies Scale. As 
well as a total score, the domains of dietary choices, self- 
monitoring strategies, physical activity and psychological 
coping are measured.42
Objective assessment of self-weighing/adherence (intervention 
group)
As an objective measure of compliance, the intervention 
group will be given weighing scales (BodyTrace, USA) 
that objectively record weight every time participants 
weigh themselves and then this information is remotely 
transmitted back to the research team at the University of 
Birmingham. These scales are only included as an objec-
tive process measure of adherence to self- weighing and 
we will not provide any feedback to participants, nor will 
we monitor changes in weight during the trial follow- up 
period.
Weight record cards (intervention group)
The intervention group will complete weight record cards 
and we will collect these from participants as a measure 
of intervention implementation at the follow- up visit. The 
record cards will also tell us how much of the intervention 
was delivered by practice nurses per protocol.
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Perceptions of regular self-weighing (intervention group)
In the intervention group, we will use five items from 
Steinberg’s Daily Self- Weighing Perceptions Question-
naire46 to measure perceptions of regular monitoring of 
weight at follow- up.
Use of the POWeR online programme (intervention group)
Using participants’ unique usernames POWeR automati-
cally records participants’ usage of the website (eg, pages 
visited, when/for how long, goals and weights entered 
and dates).
Attendance at immunisation appointments (both groups)
To ensure the intervention does not have an adverse 
impact on women attending the immunisation appoint-
ments all practices will be asked to provide data on all 
immunisation appointments attended by both groups. 
Any missed appointments will be investigated and a reason 
allocated by the GP surgery. We will also collect patient 
reported attendance at the immunisation appointments 
at the follow- up visit.
Assessment of harms
We will not be collecting adverse events for this trial. 
Serious adverse events (SAEs) which are attributable to 
the trial intervention will be documented and reported 
from the date of consent into the PIMMS- WL study until 
30 days after the 3- month follow- up visit. SAEs or deaths 
related to pre- existing medical conditions are not consid-
ered related to the trial intervention and are therefore 
excluded from notification as SAEs.
Withdrawal
Participants will be aware that they can freely withdraw 
from the trial (or part of) at any time. Details of with-
drawal will be clearly documented. Different types of 
withdrawal are defined as:
 ► The participant would like to withdraw from trial 
treatment but is willing to be followed up in accord-
ance with the schedule of assessments.
 ► The participant would like to withdraw from trial 
treatment and is not willing to be followed up or for 
any further data to be collected.
 ► The participant wishes to withdraw completely and 
is not willing to have any of their data, including 
that already collected, to be used in any future trial 
analysis.
The details of withdrawal (date, reason and type of with-
drawal) should be clearly documented in the source data.
If a recruited GP practice withdraws from participation 
in the trial prior to randomisation, they may be replaced 
by another practice. If a practice withdraws after rando-
misation, consideration will be given to replacing with 
another practice.
statistical analysis
A separate statistical analysis plan will provide a more 
comprehensive description of the planned analyses. A 
brief outline of the planned analyses in relation to the 
stop- go criteria is provided below. The data analysis for 
this feasibility trial will be descriptive and mainly focus on 
CI estimation, with no hypothesis testing performed.
The recruitment rate will be presented as a percentage 
based on the number of participants who took part in the 
trial divided by the target recruitment (n=80). BWCH will 
also provide data on the number of invitation letters sent, 
along with data on the age and ethnicity (in summary 
format) of the women who were sent an invitation letter.
The quantitative assessment of whether the interven-
tion is acceptable will be based on the adherence of 
women to weekly self- weighing and use of the online 
POWeR programme. In the first instance, the objective 
recording of weight on the scales will be used to assess the 
frequency of self- weighing/adherence.
In addition, to check that the intervention has no 
adverse impact on infant immunisation rates, the propor-
tion of babies who attended all three immunisation 
appointments will be reported for each practice (both 
groups) and the rate compared with the normal immuni-
sation rate for the practice. Reasons for missed appoint-
ments will be summarised descriptively. Recruitment, 
adherence and immunisation rates will be summarised as 
proportions with 95% CIs.
Qualitative study
We will use semi- structured interviews after trial follow- up 
to explore the views of women about the intervention and 
experiences of the practice nurses delivering the interven-
tion.47 Topic guides will be informed by existing literature.
We will purposively sample up to 15 women (eg, age, 
ethnicity, socioeconomic status and BMI category at 
enrolment) and 8 to 10 practice nurses and ask them 
about their experiences of the trial, to allow for theme 
saturation to be reached.48 49 Interviews will be conducted 
using a topic guide which will explore the women’s expe-
riences of and attitudes to trial participation, their under-
standing and rating of the importance of postnatal weight 
management, strategies used for weight management and 
their use of the online weight programme. For practice 
nurses, we will explore their experiences of delivering the 
intervention, barriers and facilitators, the content and 
phrasing of discussions with women about weight and 
views about the approaches that work best and least well. 
The objectives of the qualitative study are summarised in 
online supplementary table 4.
It is anticipated that interviews will take place face- to- face, 
but it is possible for logistical reasons that some will need 
to take place by telephone. Interviews will be recorded 
and transcribed with the permission of participants and 
thematically analysed using the Framework Method.50 Data 
management will be facilitated by the use of QSR NVivo 
11.51 A list of overall and individual themes for women and 
practice nurses will be compiled to allow for cross group/
individual comparison. Data collection and analysis will 
be iterative. All digitally recorded data that is collected 
during interviews will be recorded on an encrypted audio 
recording device. The transcriptions will be anonymised.
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decision to progress to the phase III trial
For the phase III trial to take place there needs to be 
evidence from this feasibility trial of meeting prespeci-
fied stop- go rules. The trial is too small to include mean-
ingful and sensitive stop- go criteria regarding the impact 
of the intervention on immunisation rates. However, we 
will check that the intervention has not adversely affected 
usual immunisation rates at each GP practice (as described 
above). The criteria to proceed to the phase III trial will 
be based on three criteria: recruitment rate, adherence 
to weekly self- weighing and registration with the online 
weight loss programme (POWeR) using the traffic light 
system shown in online supplementary table 3.
data collection and management
All data will be entered onto the PIMMS- WL trial data-
base. All trial paperwork will be stored in lockable filing 
cabinets in a secure, swipe access part of the University of 
Birmingham. Password protected electronic databases, on 
secure University of Birmingham servers for trial data will 
have access limited to BCTU members of staff working on 
the trial. Further trial information on data management 
procedures is available on request via BCTU including 
data collection forms.
EthICs And dIssEMInAtIon
The study will be conducted according to the principles 
of the Declaration of Helsinki and in accordance with 
other relevant national guidelines, regulations and acts.
Monitoring and oversight
The trial will form part of a portfolio of studies hosted and 
managed by BCTU. The University of Birmingham holds 
the relevant insurance for this study and is the nominated 
sponsor for this study.
As this is a feasibility trial, we do not propose to hold 
a Data Monitoring and Ethics Committee. A TSC will 
provide overall supervision and oversight of the trial 
and ensure it is conducted in accordance with the prin-
ciples of good clinical practice and relevant regulations. 
The TSC agreed the trial protocol and will agree to any 
protocol amendments. Submission of amendments and 
communication to the relevant stakeholders will be coor-
dinated by BCTU. The TSC will include members who are 
independent of the investigators, their employing organi-
sations, funders and sponsors. The TSC will monitor trial 
progress and conduct and advise on scientific credibility. 
An explicit purpose of the TSC is to monitor the immuni-
sation uptake rates at the GP practices.
dissemination
A lay summary of the study is available on the National 
Institute for Health Research website (https:// bepar-
tofresearch. nihr. ac. uk/ trial- details/ trial- detail? trialId= 
17314& location=& distance=). Final results of this feasi-
bility study will be made publicly available through 
publication in peer- reviewed journals and presented at 
relevant conferences.
dIsCussIon
The postnatal period is characterised not only by weight 
retention, but also by susceptibility to further weight gain. 
Most trials in this population include small sample sizes 
and/or evaluated intensive weight loss interventions. 
These types of interventions cannot be offered to all 
women who give birth in the UK every year. This study will 
generate evidence as to whether a full phase III trial to test 
the effectiveness of this novel postnatal weight manage-
ment intervention embedded within existing primary 
care contacts is feasible. Currently there is no national 
guidance for health professionals regarding postnatal 
weight management and the full trial testing the effec-
tiveness of this intervention would have the potential to 
influence policy and future national guidelines.
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